Health Canada has received a submission from Moderna for approval of its COVID-19 vaccine for children aged six to 11, the department reported Tuesday.
Health Canada will review it and decide whether or not to approve the vaccine based on whether the benefits outweigh any possible risks.
This will involve review of clinical trial data submitted by Moderna.
This is the second vaccine for kids under 12 that Health Canada is examining. It received a submission from Pfizer on Oct. 18, 2021.
The regulator says it’s monitoring the rollout of the Pfizer-BioNTech shot for children in the U.S., where the vaccine was authorized for use earlier this month. Health Canada said Friday it expects to issue a decision on this shot in one or two weeks.
The general manager of Moderna Canada has said interim data for its pediatric vaccine shows a strong safety profile as well as a strong immune response.
Comments